Clinical trials in Palma – page 22

The cancer research activity in Palma De Mallorca focuses on improving treatment options for multiple myeloma, relapsed refractory multiple myeloma, acute myeloid leukemia, myelodysplastic syndrome, and advanced non-small cell lung cancer. These studies are designed to assess whether newer therapies can improve disease control and patient outcomes.

• Relapsed and refractory multiple myeloma
• Newly diagnosed acute myeloid leukemia and myelodysplastic syndrome
• Advanced non-small cell lung cancer with KRAS G12C mutation
• Evaluating treatment effectiveness and disease response

Across these trials, researchers are comparing innovative approaches with existing care to better understand how to extend survival and deepen responses.

Clinical trial work in cardiovascular diseases is centered on primary prevention of atherosclerotic cardiovascular disease. The main goal is to see whether new preventive strategies can lower the risk of serious heart and vascular events in people at elevated risk.

• Atherosclerotic cardiovascular disease prevention
• Reducing major adverse cardiovascular events
• Testing preventive treatment effectiveness

These studies aim to strengthen early prevention and support better long-term cardiovascular health.

This research area includes studies in hematologic cancers such as multiple myeloma, relapsed refractory multiple myeloma, acute myeloid leukemia, and myelodysplastic syndrome. The focus is on testing therapies that may improve control of blood-related malignancies and deepen treatment responses.

• Multiple myeloma and relapsed refractory disease
• Acute myeloid leukemia
• Myelodysplastic syndrome
• Assessing therapeutic benefit in blood cancers

Investigators are working to refine treatment strategies for patients with difficult-to-treat hematologic conditions.

Trials in nervous system diseases are exploring better ways to prevent and ease chronic postsurgical pain after inguinal hernia repair. The aim is to reduce the chance that short-term surgical pain becomes a lasting problem.

• Chronic postsurgical pain
• Pain after inguinal hernia repair
• Improving postoperative symptom control

These studies focus on making recovery more comfortable and helping patients return to normal activity more smoothly.

Research in stomatognathic diseases is examining ways to prevent clinically relevant oral bleeding after tooth extraction in patients using direct oral anticoagulants or vitamin K antagonists. The purpose is to improve safety in everyday dental care for people on blood-thinning treatment.

• Oral bleeding after tooth extraction
• Patients treated with anticoagulants
• Preventing postoperative hematomas

These studies aim to support safer dental procedures without compromising cardiovascular protection.